Hemorrhoids detected at colonoscopy: An infrequent cause of false-positive fecal immunochemical test results

Gastrointestinal Endoscopy

Volumn 76, Issue 1, 2012, Pages 136-143

  Van Turenhout, Sietze T ^a   Oort, Frank A ^a   Terhaar Sive Droste, Jochim S ^a   Coupé, Veerle M H ^a   Van Der Hulst, Rene W ^b   Loffeld, Ruud J ^c   Scholten, Pieter ^d   Depla, Annekatrien C T M ^e   Bouman, Anneke A ^a   Meijer, Gerrit A ^c   Mulder, Chris J J ^a   Van Rossum, Leo G M ^a,f  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Gastroenterology and Hepatology   (Netherlands)

^c ZAANS MEDICAL CENTER   (Netherlands)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^e SLOTERVAART HOSPITAL   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; FALSE POSITIVE RESULT; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; HEMORRHOID; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOMA; AGED; ANUS DISEASES; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMORRHOIDS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OCCULT BLOOD;

EID: 84862688675     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2012.03.169     Document Type: Article

References (26)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81.
2. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-5.
4. Kronborg O, Regula J. Population screening for colorectal cancer: advantages and drawbacks. Dig Dis 2007;25:270-3.
5. Kaminski MF, Regula J. Colorectal cancer screening by colonoscopy-current issues. Digestion 2007;76:20-5.
6. Neerincx M, Terhaar sive Droste JS, Mulder CJ, et al. Colonic work-up after incomplete colonoscopy: significant new findings during followup. Endoscopy 2010;42:730-5.
7. Bretagne JF, Hamonic S, Piette C, et al. Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing. Gastrointest Endosc 2010;71:335-41.
8. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random Comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
9. Hol L, Van Leerdam ME, van BM, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8.
10. Oort FA, Terhaar sive Droste JS, van der Hulst RW, et al. Colonoscopycontrolled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Aliment Pharmacol Ther 2010;31:432-9.
11. Terhaar sive Droste JS, Oort FA, van der Hulst RW, et al. Higher fecal immunochemical test cut-off levels: lower positivity rates but still acceptable detection rates for early stage colorectal cancers. Cancer Epidemiol Biomarkers Prev 2011;20:272-80.
12. Oort FA, van Turenhout ST, Coupe VM, et al. Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study. BMC Cancer 2011;11:434.
13. Rozen P, Waked A, Vilkin A, et al. Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood. Med Sci Monit 2006;12:MT27-32.
14. Clinical Practice Committee, American Gastroenterological Association medical position statement: diagnosis and treatment of hemorrhoids. Gastroenterology 2004;126:1461-2.
15. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006;56:160-7.
16. Nakama H, Kamijo N, Fujimori K, et al. Immunochemical fecal occult blood test is not suitable for diagnosis of hemorrhoids. Am J Med 1997;102:551-4.
17. Duffy MJ, van Rossum LG, van Turenhout ST, et al. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer 2011;128:3-11.
18. Levi Z, Vilkin A, Niv Y. Esophago-gastro-duodenoscopy is not indicated in patients with positive immunochemical test and nonexplanatory colonoscopy. Eur J Gastroenterol Hepatol 2010;22:1431-4.
19. van Rijn JC, Reitsma JB, Stoker J, et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101:343-50.
20. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795-803.
21. Riss S, Weiser FA, Schwameis K, et al. The prevalence of hemorrhoids in adults. Int J Colorectal Dis 2012;271-215-20.
22. Haas PA, Haas GP, Schmaltz S, et al. The prevalence of hemorrhoids. Dis Colon Rectum 1983;26:435-9.
23. Johanson JF, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterology 1990;98:380-6.
24. Kaidar-Person O, Person B, Wexner SD. Hemorrhoidal disease: a comprehensive review. J Am Coll Surg 2007;204:102-17.
25. Sadahiro S, Mukai M, Tokunaga N, et al. A new method of evaluating hemorrhoids with the retroflexed fiberoptic colonoscope. Gastrointest Endosc 1998;48:272-5.
26. Fukuda A, Kajiyama T, Kishimoto H, et al. Colonoscopic classification of internal hemorrhoids: usefulness in endoscopic band ligation. J Gastroenterol Hepatol 2005;20:46-50.